Endocrine Testing Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Endocrine Testing Market to 2027 - Global Analysis and Forecasts By Test (Thyroid, Insulin, Follicle Stimulating Hormone, Estradiol, Testosterone, Luteinizing Hormone, Progesterone, DHEA-S, Prolactin, Human Chorionic Gonadotropin, Cortisol and Others); Technology (Immunoassay, Tandem Mass Spectrometry, Monoclonal and Polyclonal Antibody, Sensor Technology, Clinical Chemistry and others); End User (Hospitals, Diagnostic Laboratory and Others); Technology (Immunoassay, Tandem Mass Spectrometry, Monoclonal and Polyclonal Antibody, Sensor Technology, Clinical Chemistry and others)

Report Code: TIPRE00004158 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
MARKET INTRODUCTION
Endocrine Testing is performed to measure the endocrine hormone concentration for diagnosing various disorders such as diabetes, hypothyroidism, infertility and other hormonal disorder.

MARKET DYNAMICS
The Endocrine Testing market is anticipated to grow in the forecast, owing to the factors such as rising prevalence of endocrinal disorders such as diabetes, infertility etc., launch of new products, growing prevalence of lifestyle disease, growing population of obese patients, rising geriatric population and increasing government support. Nevertheless, unaffordability of the Endocrine Testing Equipment and lack of awareness in certain regions is expected to hamper the market growth during the forecast period.

MARKET SCOPE
The "Global Endocrine Testing Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Endocrine Testing market with detailed market segmentation by Test, Technology, End User and geography. The global Endocrine Testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Endocrine Testing Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Endocrine Testing market is segmented on the basis of Test, Technology and End User. Based on Test the market is segmented into Thyroid, Insulin, Follicle Stimulating Hormone, Estradiol, Testosterone, Luteinizing Hormone, Progesterone, DHEA-S, Prolactin, Human Chorionic Gonadotropin, Cortisol and Others. Based on Technology the market is segmented into Immunoassay, Tandem Mass Spectrometry, Monoclonal and Polyclonal Antibody, Sensor Technology, Clinical Chemistry and others. Based on End User the market is segmented into Hospitals, Diagnostic Laboratory and Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Endocrine Testing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Endocrine Testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Endocrine Testing market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Endocrine Testing market in these regions.

MARKET PLAYERS
The reports cover key developments in the Endocrine Testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Endocrine Testing market are anticipated to lucrative growth opportunities in the future with the rising demand for Endocrine Testing market in the global market. Below mentioned is the list of few companies engaged in the Endocrine Testing market.

The report also includes the profiles of Endocrine Testing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Abbott Laboratories
  • AB Sciex Pte. Ltd
  • Agilent Technologies
  • Biomedical Technologies
  • DiaSorin S.p.A
  • F.Hoffmann-La Roche Ltd
  • LabCorp
  • Ortho Clinical Technologies
  • Quest Technology
  • Siemens Healthcare
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Endocrine Testing Market - By Test
1.3.2 Endocrine Testing Market - By Technology
1.3.3 Endocrine Testing Market - By End User
1.3.4 Endocrine Testing Market - By Technology
1.3.5 Endocrine Testing Market - By Region
1.3.5.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. ENDOCRINE TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ENDOCRINE TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ENDOCRINE TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. ENDOCRINE TESTING - GLOBAL MARKET OVERVIEW
6.2. ENDOCRINE TESTING - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ENDOCRINE TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TEST
7.1. OVERVIEW
7.2. TEST MARKET FORECASTS AND ANALYSIS
7.3. THYROID
7.3.1. Overview
7.3.2. Thyroid Market Forecast and Analysis
7.4. INSULIN
7.4.1. Overview
7.4.2. Insulin Market Forecast and Analysis
7.5. FOLLICLE STIMULATING HORMONE
7.5.1. Overview
7.5.2. Follicle Stimulating Hormone Market Forecast and Analysis
7.6. ESTRADIOL
7.6.1. Overview
7.6.2. Estradiol Market Forecast and Analysis
7.7. TESTOSTERONE
7.7.1. Overview
7.7.2. Testosterone Market Forecast and Analysis
7.8. LUTEINIZING HORMONE
7.8.1. Overview
7.8.2. Luteinizing Hormone Market Forecast and Analysis
7.9. PROGESTERONE
7.9.1. Overview
7.9.2. Progesterone Market Forecast and Analysis
7.10. DHEA-S
7.10.1. Overview
7.10.2. DHEA-S Market Forecast and Analysis
7.11. PROLACTIN
7.11.1. Overview
7.11.2. Prolactin Market Forecast and Analysis
7.12. HUMAN CHORIONIC GONADOTROPIN
7.12.1. Overview
7.12.2. Human Chorionic Gonadotropin Market Forecast and Analysis
7.13. CORTISOL AND OTHERS
7.13.1. Overview
7.13.2. Cortisol and Others Market Forecast and Analysis
8. ENDOCRINE TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. IMMUNOASSAY
8.3.1. Overview
8.3.2. Immunoassay Market Forecast and Analysis
8.4. TANDEM MASS SPECTROMETRY
8.4.1. Overview
8.4.2. Tandem Mass Spectrometry Market Forecast and Analysis
8.5. MONOCLONAL AND POLYCLONAL ANTIBODY
8.5.1. Overview
8.5.2. Monoclonal and Polyclonal Antibody Market Forecast and Analysis
8.6. SENSOR TECHNOLOGY
8.6.1. Overview
8.6.2. Sensor Technology Market Forecast and Analysis
8.7. CLINICAL CHEMISTRY AND OTHERS
8.7.1. Overview
8.7.2. Clinical Chemistry and others Market Forecast and Analysis
9. ENDOCRINE TESTING MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTIC LABORATORY AND OTHERS
9.4.1. Overview
9.4.2. Diagnostic Laboratory and Others Market Forecast and Analysis
10. ENDOCRINE TESTING MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
10.1. OVERVIEW
10.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
10.3. IMMUNOASSAY
10.3.1. Overview
10.3.2. Immunoassay Market Forecast and Analysis
10.4. TANDEM MASS SPECTROMETRY
10.4.1. Overview
10.4.2. Tandem Mass Spectrometry Market Forecast and Analysis
10.5. MONOCLONAL AND POLYCLONAL ANTIBODY
10.5.1. Overview
10.5.2. Monoclonal and Polyclonal Antibody Market Forecast and Analysis
10.6. SENSOR TECHNOLOGY
10.6.1. Overview
10.6.2. Sensor Technology Market Forecast and Analysis
10.7. CLINICAL CHEMISTRY AND OTHERS
10.7.1. Overview
10.7.2. Clinical Chemistry and others Market Forecast and Analysis
11. ENDOCRINE TESTING MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
11.1. NORTH AMERICA
11.1.1 North America Endocrine Testing Market Overview
11.1.2 North America Endocrine Testing Market Forecasts and Analysis
11.1.3 North America Endocrine Testing Market Forecasts and Analysis - By Test
11.1.4 North America Endocrine Testing Market Forecasts and Analysis - By Technology
11.1.5 North America Endocrine Testing Market Forecasts and Analysis - By End User
11.1.6 North America Endocrine Testing Market Forecasts and Analysis - By Technology
11.1.7 North America Endocrine Testing Market Forecasts and Analysis - By Countries
11.1.7.1 United States Endocrine Testing Market
11.1.7.1.1 United States Endocrine Testing Market by Test
11.1.7.1.2 United States Endocrine Testing Market by Technology
11.1.7.1.3 United States Endocrine Testing Market by End User
11.1.7.1.4 United States Endocrine Testing Market by Technology
11.1.7.2 Canada Endocrine Testing Market
11.1.7.2.1 Canada Endocrine Testing Market by Test
11.1.7.2.2 Canada Endocrine Testing Market by Technology
11.1.7.2.3 Canada Endocrine Testing Market by End User
11.1.7.2.4 Canada Endocrine Testing Market by Technology
11.1.7.3 Mexico Endocrine Testing Market
11.1.7.3.1 Mexico Endocrine Testing Market by Test
11.1.7.3.2 Mexico Endocrine Testing Market by Technology
11.1.7.3.3 Mexico Endocrine Testing Market by End User
11.1.7.3.4 Mexico Endocrine Testing Market by Technology
11.1.7.4 US Endocrine Testing Market
11.1.7.4.1 US Endocrine Testing Market by Test
11.1.7.4.2 US Endocrine Testing Market by Technology
11.1.7.4.3 US Endocrine Testing Market by End User
11.1.7.4.4 US Endocrine Testing Market by Technology
11.2. EUROPE
11.2.1 Europe Endocrine Testing Market Overview
11.2.2 Europe Endocrine Testing Market Forecasts and Analysis
11.2.3 Europe Endocrine Testing Market Forecasts and Analysis - By Test
11.2.4 Europe Endocrine Testing Market Forecasts and Analysis - By Technology
11.2.5 Europe Endocrine Testing Market Forecasts and Analysis - By End User
11.2.6 Europe Endocrine Testing Market Forecasts and Analysis - By Technology
11.2.7 Europe Endocrine Testing Market Forecasts and Analysis - By Countries
11.2.7.1 Germany Endocrine Testing Market
11.2.7.1.1 Germany Endocrine Testing Market by Test
11.2.7.1.2 Germany Endocrine Testing Market by Technology
11.2.7.1.3 Germany Endocrine Testing Market by End User
11.2.7.1.4 Germany Endocrine Testing Market by Technology
11.2.7.2 France Endocrine Testing Market
11.2.7.2.1 France Endocrine Testing Market by Test
11.2.7.2.2 France Endocrine Testing Market by Technology
11.2.7.2.3 France Endocrine Testing Market by End User
11.2.7.2.4 France Endocrine Testing Market by Technology
11.2.7.3 Italy Endocrine Testing Market
11.2.7.3.1 Italy Endocrine Testing Market by Test
11.2.7.3.2 Italy Endocrine Testing Market by Technology
11.2.7.3.3 Italy Endocrine Testing Market by End User
11.2.7.3.4 Italy Endocrine Testing Market by Technology
11.2.7.4 Spain Endocrine Testing Market
11.2.7.4.1 Spain Endocrine Testing Market by Test
11.2.7.4.2 Spain Endocrine Testing Market by Technology
11.2.7.4.3 Spain Endocrine Testing Market by End User
11.2.7.4.4 Spain Endocrine Testing Market by Technology
11.2.7.5 United Kingdom Endocrine Testing Market
11.2.7.5.1 United Kingdom Endocrine Testing Market by Test
11.2.7.5.2 United Kingdom Endocrine Testing Market by Technology
11.2.7.5.3 United Kingdom Endocrine Testing Market by End User
11.2.7.5.4 United Kingdom Endocrine Testing Market by Technology
11.3. ASIA-PACIFIC
11.3.1 Asia-Pacific Endocrine Testing Market Overview
11.3.2 Asia-Pacific Endocrine Testing Market Forecasts and Analysis
11.3.3 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By Test
11.3.4 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By Technology
11.3.5 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By End User
11.3.6 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By Technology
11.3.7 Asia-Pacific Endocrine Testing Market Forecasts and Analysis - By Countries
11.3.7.1 Australia Endocrine Testing Market
11.3.7.1.1 Australia Endocrine Testing Market by Test
11.3.7.1.2 Australia Endocrine Testing Market by Technology
11.3.7.1.3 Australia Endocrine Testing Market by End User
11.3.7.1.4 Australia Endocrine Testing Market by Technology
11.3.7.2 China Endocrine Testing Market
11.3.7.2.1 China Endocrine Testing Market by Test
11.3.7.2.2 China Endocrine Testing Market by Technology
11.3.7.2.3 China Endocrine Testing Market by End User
11.3.7.2.4 China Endocrine Testing Market by Technology
11.3.7.3 India Endocrine Testing Market
11.3.7.3.1 India Endocrine Testing Market by Test
11.3.7.3.2 India Endocrine Testing Market by Technology
11.3.7.3.3 India Endocrine Testing Market by End User
11.3.7.3.4 India Endocrine Testing Market by Technology
11.3.7.4 Japan Endocrine Testing Market
11.3.7.4.1 Japan Endocrine Testing Market by Test
11.3.7.4.2 Japan Endocrine Testing Market by Technology
11.3.7.4.3 Japan Endocrine Testing Market by End User
11.3.7.4.4 Japan Endocrine Testing Market by Technology
11.4. MIDDLE EAST AND AFRICA
11.4.1 Middle East and Africa Endocrine Testing Market Overview
11.4.2 Middle East and Africa Endocrine Testing Market Forecasts and Analysis
11.4.3 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By Test
11.4.4 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By Technology
11.4.5 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By End User
11.4.6 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By Technology
11.4.7 Middle East and Africa Endocrine Testing Market Forecasts and Analysis - By Countries
11.4.7.1 South Africa Endocrine Testing Market
11.4.7.1.1 South Africa Endocrine Testing Market by Test
11.4.7.1.2 South Africa Endocrine Testing Market by Technology
11.4.7.1.3 South Africa Endocrine Testing Market by End User
11.4.7.1.4 South Africa Endocrine Testing Market by Technology
11.4.7.2 Saudi Arabia Endocrine Testing Market
11.4.7.2.1 Saudi Arabia Endocrine Testing Market by Test
11.4.7.2.2 Saudi Arabia Endocrine Testing Market by Technology
11.4.7.2.3 Saudi Arabia Endocrine Testing Market by End User
11.4.7.2.4 Saudi Arabia Endocrine Testing Market by Technology
11.4.7.3 U.A.E Endocrine Testing Market
11.4.7.3.1 U.A.E Endocrine Testing Market by Test
11.4.7.3.2 U.A.E Endocrine Testing Market by Technology
11.4.7.3.3 U.A.E Endocrine Testing Market by End User
11.4.7.3.4 U.A.E Endocrine Testing Market by Technology
11.5. SOUTH AND CENTRAL AMERICA
11.5.1 South and Central America Endocrine Testing Market Overview
11.5.2 South and Central America Endocrine Testing Market Forecasts and Analysis
11.5.3 South and Central America Endocrine Testing Market Forecasts and Analysis - By Test
11.5.4 South and Central America Endocrine Testing Market Forecasts and Analysis - By Technology
11.5.5 South and Central America Endocrine Testing Market Forecasts and Analysis - By End User
11.5.6 South and Central America Endocrine Testing Market Forecasts and Analysis - By Technology
11.5.7 South and Central America Endocrine Testing Market Forecasts and Analysis - By Countries
11.5.7.1 Brazil Endocrine Testing Market
11.5.7.1.1 Brazil Endocrine Testing Market by Test
11.5.7.1.2 Brazil Endocrine Testing Market by Technology
11.5.7.1.3 Brazil Endocrine Testing Market by End User
11.5.7.1.4 Brazil Endocrine Testing Market by Technology
11.5.7.2 Argentina Endocrine Testing Market
11.5.7.2.1 Argentina Endocrine Testing Market by Test
11.5.7.2.2 Argentina Endocrine Testing Market by Technology
11.5.7.2.3 Argentina Endocrine Testing Market by End User
11.5.7.2.4 Argentina Endocrine Testing Market by Technology
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. ENDOCRINE TESTING MARKET, KEY COMPANY PROFILES
13.1. ABBOTT LABORATORIES
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. AB SCIEX PTE. LTD
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. AGILENT TECHNOLOGIES
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. BIOMEDICAL TECHNOLOGIES
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. DIASORIN S.P.A
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. F.HOFFMANN-LA ROCHE LTD
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. LABCORP
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ORTHO CLINICAL TECHNOLOGIES
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. QUEST TECHNOLOGY
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. SIEMENS HEALTHCARE
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TER
The List of Companies

- Abbott Laboratories
- AB Sciex Pte. Ltd
- Agilent Technologies
- Biomedical Technologies
- DiaSorin S.p.A
- F.Hoffmann-La Roche Ltd
- LabCorp
- Ortho Clinical Technologies
- Quest Technology
- Siemens Healthcare
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book